CRISPR Therapeutics to Present at Investor Conferences in May – Nasdaq
Chaffey BreezeCRISPR Therapeutics to Present at Investor Conferences in MayNasdaqBASEL, Switzerland and CAMBRIDGE, Mass., May 12, 2017 (GLOBE NEWSWIRE) — CRISPR Therapeutics (NASDAQ:CRSP), a biopharmaceutical company focused on translating CRISPR-Cas… Continue reading
